Close

Paul Moayyedi
Professor, Department of Medicine
[vc_row][vc_column width="1/3"][thb_image image="139" img_size="full"][/vc_column][vc_column width="2/3"][vc_column_text]

Paul Moayyedi, BSc, MB ChB, PhD, MPH, FRCP, FRCPC, FACG, AGAF

Professor, Department of Medicine Director of Clinical Research, Farncombe Family Digestive Health Research Institute Director, Division of Gastroenterology Email: moayyep@mcmaster.ca[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][thb_gap height="30"][vc_tta_tabs][vc_tta_section title="Research Areas" tab_id="1437453832940-5fbb4e66-ae2af655-555c7eba-7775"][vc_column_text]

Health Services Research in Gastroenterology

Focus

Dr. Moayyedi has a strong interest in evidence based medicine. He qualified in Medicine from Bristol University, UK and obtained a PhD in Medicine as well as a Master's in Public Health from the University of Leeds, UK. He was appointed Director of the Division of Gastroenterology in 2006. He has conducted a number of large randomized controlled trials and epidemiological studies that have evaluated functional and organic disease of the GI tract. He has also published several systematic reviews that have been influential in British, American and Canadian national guidelines. He is the joint Coordinating Editor for the Upper Gastrointestinal and Pancreatic Diseases Cochrane Review Group based at McMaster and is also Co-Editor-in-Chief of the American Journal of Gastroenterology.

Methodologies

Epidemiology, biostatistics, systematic review and meta-analysis, clinical trials, health economics, decision modeling.

[/vc_column_text][/vc_tta_section][vc_tta_section title="Funding" tab_id="1443814514244-5a5c08df-e2ae"][vc_column_text]

Project 1

Title: Aspirin and PPIs to prevent mortality in Barrett’s patients Funders: Cancer Research UK and AstraZeneca Role: Deputy Principal Investigator Duration: 2004-2014

Project 2

Title: Barrett’s esophagus two yearly surveillance vs. no surveillance: a randomized controlled trial to estimate cost-effectiveness (BOSS) Funders: National NHS R&D HTA program Role: Principal Investigator Duration: 2008-2019

Project 3

Title: The Michael J. Howorth GEM Project Funders: Crohn’s and Colitis Foundation of Canada Role: GEM Executive Team Duration: 2007-2013

Project 4

Title: Cohort study of inflammatory bowel disease after acute enteric infection in Walkerton, Ontario. Funders: Crohn’s and Colitis Foundation of Canada Role: Co-investigator (Principal Investigator Dr. John Marshall) Duration: 2005-2008[/vc_column_text][/vc_tta_section][vc_tta_section title="Publications" tab_id="1437453833574-69cc703e-4bbff655-555c7eba-7775"][vc_column_text] [pmid-refs key="moayyedi_p" limit=10] [/vc_column_text][/vc_tta_section][/vc_tta_tabs][/vc_column][/vc_row]